文献速递脑血管病

急性缺血性卒中伴重度颅内狭窄:即刻血管成形或支架术对功能结局的效果

Effectiveness of Immediate Angioplasty or Stenting on Functional Outcomes in Acute Ischemic Stroke With Severe Intracranial Stenosis.
PubMed 文献 · Neurology · 2026-06-10

该多中心回顾性研究纳入242例发病24小时内、影像证实责任血管重度颅内狭窄(70%-99%)的急性缺血性卒中患者,比较即刻血管成形或支架术与单纯标准药物治疗。结果显示介入组90天mRS分布更优(校正共同OR 2.73,95%CI 1.49-5.00,p=0.001),症状性颅内出血和死亡率无显著差异。

要点

  • 即刻血管成形或支架术与90天功能结局改善相关(校正共同OR 2.73)。
  • 症状性颅内出血和90天死亡率与标准药物治疗无显著差异。
  • 证据等级为Class III,需进一步研究确认。

核心结论

  • 在无闭塞的重度颅内狭窄急性缺血性卒中患者中,即刻血管成形或支架术与90天功能结局改善相关。
  • 症状性颅内出血发生率和90天死亡率与单纯标准药物治疗相比无显著差异。

研究设计与样本

  • 主要结局为90天改良Rankin量表(mRS)评分分布,采用多变量校正模型和逆概率治疗加权(IPTW)估计疗效。

主要发现

  • 即刻血管成形或支架术组90天mRS中位数为1(四分位距0-3),标准药物治疗组为1(四分位距1-3)。
  • 校正后共同OR为2.73(95%CI 1.49-5.00,p=0.001);IPTW后OR为2.50(95%CI 1.72-3.63,p<0.001),均提示介入组功能结局更优。
  • 症状性颅内出血发生率介入组1.0% vs 标准药物组1.4%(校正风险比0.36,95%CI 0.02-5.35,p=0.46)。
  • 90天死亡率介入组2.1% vs 标准药物组1.4%(校正风险比1.01,95%CI 0.92-1.11,p=0.93)。

关键数值与推荐

  • 重度颅内狭窄定义为70%-99%,采用Warfarin Asprin Symptomatic Intracranial Disease(WASID)标准。
  • 主要疗效指标为90天mRS评分分布,校正共同OR 2.73(95%CI 1.49-5.00,p=0.001)。
  • 安全性指标包括24小时内症状性颅内出血和90天死亡率。

临床怎么用

  • 对于发病24小时内、影像证实责任血管重度颅内狭窄(70%-99%)且无闭塞的急性缺血性卒中患者,即刻血管成形或支架术可能改善90天功能结局。
  • 该干预未增加症状性颅内出血或死亡风险,但证据等级为Class III,需结合个体情况谨慎决策。

局限性

  • 回顾性研究设计可能存在选择偏倚和残余混杂。
  • 样本量有限(242例),安全性事件发生率低,置信区间宽。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The efficacy of endovascular treatment for acute large vessel occlusion strokes has been demonstrated, but whether it can improve functional outcomes in patients with acute ischemic stroke (AIS) who only present with severe large vessel stenosis without occlusion has not yet been studied. This study investigates the effectiveness of immediate angioplasty or stenting on functional outcomes in AIS patients with severe intracranial stenosis without occlusion. METHODS: We retrospectively included patients with AIS with symptom onset within 24 hours and imaging-confirmed severe intracranial stenosis (70%-99%, Warfarin Asprin Symptomatic Intracranial Disease criteria) of the culprit vessel from 7 centers in China between January 1, 2020, and December 31, 2024. We compared patients undergoing immediate angioplasty or stenting with those receiving standard medical treatment (SMT) alone. The primary outcome was the distribution of modified Rankin Scale (mRS) scores at 90 days. The treatment effect was estimated through multivariable adjusted models and inverse probability of treatment weighting (IPTW). Safety outcomes included symptomatic intracranial hemorrhage (sICH) within 24 hours and mortality within 90 days. RESULTS: A total of 242 patients were included, with a mean age of 65.7 years, and 86 patients (35.5%) were female. Ninety-six (39.7%) patients underwent immediate angioplasty or stenting, and 146 (60.3%) received SMT. The median 90-day mRS score was 1 (interquartile range 0-3) in the immediate angioplasty or stenting group and 1 (interquartile range 1-3) in the SMT group. The immediate angioplasty or stenting group showed a shift toward better functional outcomes on the mRS scores (adjusted common odds ratio [OR] 2.73 [95% CI 1.49-5.00], p = 0.001; after IPTW, OR 2.50 [95% CI 1.72-3.63], p < 0.001). There was no significant difference in the incidence of sICH (1.0% vs 1.4%; adjusted risk ratio 0.36 [95% CI 0.02-5.35], p = 0.46) or mortality (2.1% vs 1.4%; adjusted hazard ratio 1.01 [95% CI 0.92-1.11], p = 0.93). DISCUSSION: Among patients with AIS with severe intracranial stenosis without occlusion, immediate angioplasty or stenting was associated with improved 90-day functional outcomes compared with SMT alone. No significant difference was observed in the incidence of sICH or mortality. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that in AIS patients with severe intracranial stenosis, immediate angioplasty or stenting was associated with improved 90-day functional outcomes compared with SMT.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Chen X, Yi T, Cao W, et al. Effectiveness of Immediate Angioplasty or Stenting on Functional Outcomes in Acute Ischemic Stroke With Severe Intracranial Stenosis. Neurology. 2026. PMID: 42269124. doi:10.1212/WNL.0000000000218157

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。